[1]
Bruggmann, P., Blach, S., Deltenre, P., Fehr, J., Kouyos, R.D., Lavanchy, D., Müllhaupt, B., Rauch, A., Razavi, H., Schmid, P., Semela, D., Stöckle, M. and Negro, F. 2017. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. Swiss Medical Weekly. 147, 4546 (Nov. 2017), w14543. DOI:https://doi.org/10.4414/smw.2017.14543.